Schedule of Shareholder Equity Total Warrants Outstanding (Details) - shares |
9 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|
Sep. 30, 2026 |
Dec. 31, 2025 |
||||
| Equity [Abstract] | |||||
| Warrants outstanding, beginning | 701,104 | 44,445 | |||
| Warrants issued | 633,587 | 750,854 | |||
| Warrants exercised | (499,107) | [1] | (63,083) | ||
| Warrants exchanged | (31,112) | ||||
| Warrants expired | |||||
| Warrants outstanding, ending | 835,584 | 701,104 | |||
| |||||
| X | ||||||||||
- Definition Number of non-option equity instruments exchanged by participants. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|